secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001829126-26-004744
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO announces 1-for-50 reverse stock split effective May 8, 2026
---------------------------------------------------------------------

- Reverse stock split at 1-for-50 ratio effective 4:05 p.m. ET on May 8, 2026.
- Outstanding shares reduced from 929,491,578 to ~18,589,832; no fractional shares issued.
- Cash paid for fractional shares based on May 7 closing price on Nasdaq Capital Market.
- Ticker KALA unchanged; split-adjusted trading begins May 11, 2026; new CUSIP 483119301.
- Stockholder approved reverse split at January 30, 2026 annual meeting with ratio range of 1-for-2 to 1-for-100.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/0001829126-26-004744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/kalabio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-004744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer